Vet Stuart Thorne from Fellowes Farm Equine Clinic in Abbots Ripton has praised the work of the charity-run National Foaling Bank after it helped save the life of an orphan three day old filly foal.
If you’re a show-jumping vet, you might like to take part in the first-ever international veterinary-only riders competition – held in the beautiful region of Lure at the foot of the Vosges in France.
The French association of veterinary riders (AFVC) invites all veterinary riders to contend for the First World Veterinary Equestrian Show Jumping Cup, to be held from July 3 to 6, 2008.
The event is open to all qualified veterinarians and veterinary students, who may participate with or without their own horse.
The event will include four show-jumping competitions (one per day), while the social programme consists of a Gala evening (Friday), a dinner-dance (Saturday, sponsored by Merial) and a Sunday lunch (major sponsor of the event: Equistro / Vétoquinol).
The veterinary show-jumping event will coincide with France’s 6th Grand National show-jumping competition, also held in Lure.
For further information, please contact: David Smart DVM, david.smart@vetoquinol.com or your local Vétoquinol representative.
Equistro has introduced Legaphyton to its range of supplements. Legaphyton has been developed to support liver function. It incorporates a new and patented complex called Siliphos®.
Siliphos® is a complex of concentrated Milk Thistle fruit extract and phospholipids, and is a source of readily available carbohydrates important for liver support.
Milk Thistle (silymarin) extract has documented virtues in liver support and is rich in flavanoligan (Silybin), while phospholipids (phosphatidylcholine) maintain healthy liver cell membrane function and repair and are crucial for essential lipoprotein transport in the liver.
“The liver is one of the most important organs and performs more often than one realises,” said Val Day, Equistro’s product manager. “Legaphyton has been introduced to give an extra boost to the horse’s liver function and help the liver fulfil its varied role.”
Equistro Legaphyton is available in 900g packs, which is sufficient for 30 days for a standard 500kg horse. Ask your Vetoquinol representative for more details or visit http://www.vetoquinol.co.uk/
.
A new diagnostic blood test has been developed to combat the virulent horse disease Strangles.
The breakthrough has come after four years of research by scientists at the Animal Health Trust in Newmarket.
The blood test identifies horses that have recently been exposed to Strangles, enabling it to be nipped in the bud.
Oliver Wilson, campaign director at The British Horse Society, said: "It is fantastic news. This big breakthrough is a real boon to horse owners and I believe will lead to a significant drop in Strangles outbreaks. But there is still much to be done.
"The AHT's work to develop and test a fully effective vaccine against Strangles is ongoing. To support it we need to raise another £120,000 by the end of this year to reach the campaign target of £250,000."
For more information about the Strangles campaign, visit http://www.strangles.org/
Two guides for equine veterinarians have just been produced by Hallmarq Veterinary Imaging covering the role of MRI in diagnosing lameness.
MRI Cases in the Standing Sedated Horse looks at fourteen cases from seven clinics in the Hallmarq user community. Compiled for Hallmarq by Dr Julien Olive DMV and complete with clinical MRI images, this 38 page booklet reviews the history, clinical examination, MRI examination, diagnosis, treatment and outcome of each case. The examples illustrate how MRI can enable a diagnosis to be made and a suitable course of treatment prescribed in difficult or ambiguous cases.
The second booklet, MRI Protocols for the Standing Sedated Horse, focuses on the procedures and terminology associated with MRI, from a brief description of the technology and the types of image that can be obtained, to a more detailed description of the methodology.
Hallmarq says that with 20 scanning centres now operating in the UK and Europe the ability now to refer selected cases for an MRI examination makes these booklets relevant to routine practice.
The booklets are available free of charge from Hallmarq for equine veterinarians and veterinary students, and they may be previewed on Hallmarq’s website.
Hallmarq Veterinary Imaging: (01483) 877812 or email info@hallmarq.net
Dechra Veterinary Products, manufacturer and distributor of Equipalazone®, has launched a new information leaflet to support the Equine Passport scheme.
Since 2005, when equine passports became mandatory, 958,000 have been issued. The passport is a method of identification as well as a medical record and ensures that horses treated with veterinary medicines do not enter the human food chain.
“Many substances used in commonly prescribed equine medicines can only be given to horses not intended for human consumption,” says Giles Coley, Dechra’s managing director. “Under the passport scheme, owners must declare whether their horse is intended for human consumption.
The leaflet, which outlines the importance and benefits of the Equine Passport scheme, will be inserted into every box of Equipalazone Powder 100 sachets. It will also be made available for veterinary practices to hand out to their clients.
Practices wishing or order copies of the Equine Passport leaflet should contact Rachel Horton at Dechra on 01743 441 632.
VetCell is celebrating a win at Cheltenham, after 'Knowhere' won the Cotswold Chase following pioneering stem cell treatment for a serious tendon injury.
Knowhere had had a good start to his racing career as a four-year-old, winning his first two races as a novice hurdler. But after his second race in 2004 he suffered injuries to both forelimb superficial digital flexor tendons. The left fore showed low grade tendonitis while the right fore had a significant percentage of fibre rupture. As a promising racing prospect, Knowhere’s connections wanted to give him the best possible chance of recovering from his injury so they opted for stem cell therapy. He was treated by Tim Beauregard MRCVS of Summerhill Farm in Gloucestershire.
Bone marrow samples were collected from Knowhere’s sternum and were processed in VetCell's laboratory over a five week period to generate millions of stem cells. Knowhere was sedated, the tendon area was anaesthetised and the leg was then surgically clipped and disinfected. Stem cells, which had been suspended in serum obtained from the original bone marrow sample, were then injected using ultrasound guidance, into the core of the damaged area of the tendon fibres.
For the first week after the implantation Knowhere was kept in his stable to allow the cells to adapt to their new environment. Each day after this he was given walking exercise in order to stimulate the activity of the stem cells, encouraging them to differentiate into tendon cells and form into strong tendon fibres. The amount of exercise was incrementally increased, building up over a three-month period from five minutes each day to 45 minutes twice a day.
By the autumn of 2005 both of Knowhere’s tendons had healed very well and showed good fibre pattern on ultrasonography. He was re-introduced to the racetrack the following year and of the 15 or so races he has been in since, he has finished in the frame on eight occasions and has amassed some £175,000 in winnings.
Vet Tim Beauregard said: “Knowhere’s successful return to the track has been exciting and immensely satisfying to follow and he showed particularly brilliant form in the Cotswold Chase. It remains to be seen whether he will be heading for the Ryanair Chase, the Gold Cup or the Grand National but all involved will be hoping for the best.”
For more information please contact VetCell on +44 207 691 2062 or 866 764 0340, email: info@vetcell.com or visit the website at http://www.vetcell.com/
Researchers at the University of Edinburgh’s Royal (Dick) School of Veterinary Studies are to start testing whether a compound of cooling chemicals, extracted from mint, can be used to treat laminitis, a condition which affects seven per cent of the British horse population.
The new project, funded by The Horse Trust and led by Professor Sue Fleetwood-Walker, builds on recent work that revealed for the first time that, there is significant nerve damage, as well as inflammation, within the hoof of laminitic horses. This explains why anti-inflammatory drugs are so ineffective in treating the pain of chronic laminitis and highlights the need for therapies to treat nerve injury-induced or ‘neuropathic’ pain in horses.
Prof Fleetwood-Walker’s team discovered in 2006 that the ‘mint’ chemicals have a pain–killing effect in laboratory studies of chronic pain. They will now investigate whether this synthetic treatment could help horses with laminitis.
Fort Dodge (makers of Equest equine worming brands, and Deosect), is launching a new Equine Parasites Reference Manual.
The manual, which is supported by AHDA, AMTRA and BEVA, is billed as 'an objective and comprehensive reference guide covering endoparasites and ectoparasites and their control, as well as offering prescribing tips, a glossary of terms and reference sources'.
Fort Dodge has produced the manual to provide an ‘all in one’ guide to support veterinary professionals and Suitably Qualified People (SQPs) involved in prescribing equine parasite treatments. It brings together, in an A5 spiral bound booklet, all the information they may need on the full range of licensed veterinary medicines to control equine parasites of concern in the UK. It will be launched at BETA (17-19 February at the NEC).
For further information about the manual (or to get a copy), please contact Fort Dodge on 01489 781711.
The University of Liverpool’s Philip Leverhulme Equine Hospital has installed a standing equine MRI scanner from Hallmarq Veterinary Imaging.